- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04659928
Evaluation of Aerosol in a Dental Clinic
June 18, 2025 updated by: Claudia Ruiz Brisuela, The University of Texas Health Science Center, Houston
The purpose of this study is to evaluate the effectiveness of external evacuation units and mouth rinses during aerosol generating procedures in a dental clinic and to determine the risk level to the dental practitioners during aerosol generating procedures.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- prepping natural teeth at the appointment
- at least an hour long procedure
- procedure will be the first one in the morning
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High volume evacuation (HVE) suction only and hydrogen peroxide
|
Subjects will be given 1.5 % Oral Solution of hydrogen peroxide mouth rinse
Intra oral suction will be done and during the procedure,bacterial colony forming units (cfus) will be captured during dental care by placing large format petri dishes containing bacterial culture media in the dental operatory with open lids.
Once aerosol capture is complete, petri dishes will be incubated and quantified under BSL-2 safety conditions in the lab.
Patient will be given a mouth rinse.
|
|
Experimental: HVE suction and extraoral vacuum aspirator (EVA) and hydrogen peroxide
|
Subjects will be given 1.5 % Oral Solution of hydrogen peroxide mouth rinse
Intra oral suction will be done and during the procedure,bacterial colony forming units (cfus) will be captured during dental care by placing large format petri dishes containing bacterial culture media in the dental operatory with open lids.
Once aerosol capture is complete, petri dishes will be incubated and quantified under BSL-2 safety conditions in the lab.
Patient will be given a mouth rinse.
Extraoral suction connected to dental suction will be used and bacterial colony forming units (cfus) will be captured during dental care by placing large format petri dishes containing bacterial culture media in the dental operatory with open lids.
Once aerosol capture is complete, petri dishes will be incubated and quantified under BSL-2 safety conditions in the lab.
Patient will be given mouth rinse.
|
|
Experimental: HVE suction and extraoral vacuum aspirator (EVA) and Placebo
|
Intra oral suction will be done and during the procedure,bacterial colony forming units (cfus) will be captured during dental care by placing large format petri dishes containing bacterial culture media in the dental operatory with open lids.
Once aerosol capture is complete, petri dishes will be incubated and quantified under BSL-2 safety conditions in the lab.
Patient will be given a mouth rinse.
Extraoral suction connected to dental suction will be used and bacterial colony forming units (cfus) will be captured during dental care by placing large format petri dishes containing bacterial culture media in the dental operatory with open lids.
Once aerosol capture is complete, petri dishes will be incubated and quantified under BSL-2 safety conditions in the lab.
Patient will be given mouth rinse.
Subjects will be given a placebo (plain water) mouth rinse
|
|
Experimental: High volume evacuation (HVE) suction only and Placebo
|
Intra oral suction will be done and during the procedure,bacterial colony forming units (cfus) will be captured during dental care by placing large format petri dishes containing bacterial culture media in the dental operatory with open lids.
Once aerosol capture is complete, petri dishes will be incubated and quantified under BSL-2 safety conditions in the lab.
Patient will be given a mouth rinse.
Subjects will be given a placebo (plain water) mouth rinse
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Bacterial Colony Forming Units (CFUs)
Time Frame: Baseline
|
At baseline (1 hour before treatment), four agar petri dishes will be placed at standardized distances (2 ft, 3 ft, 4 ft, and 6 ft) from the dental chair headrest in the operating room.
An impinger will also be positioned 2 ft from the headrest.
The number of bacterial colony-forming units (CFUs) will be counted for each petri dish and the impinger after a 72-hour incubation period.
The average number of Bacterial CFUs is reported.
|
Baseline
|
|
Number of Bacterial Colony Forming Units (CFUs)
Time Frame: 1 hour from the start of the treatment
|
At the start of treatment, four agar petri dishes will be placed at standardized distances (2 ft, 3 ft, 4 ft, and 6 ft) from the dental chair headrest in the operating room for one hour.
An impinger will also be positioned 2 ft from the headrest for one hour.
The number of bacterial colony-forming units (CFUs) will be counted for each petri dish and the impinger after a 72-hour incubation period.
The average number of Bacterial CFUs is reported.
|
1 hour from the start of the treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Bacterial Colony Forming Units (CFUs) at Each Location
Time Frame: Baseline
|
At baseline (1 hour before treatment), four agar petri dishes will be placed at standardized distances (2 ft, 3 ft, 4 ft, and 6 ft) from the dental chair headrest in the operating room.
An impinger will also be positioned 2 ft from the headrest.
The number of bacterial colony-forming units (CFUs) will be counted for each petri dish and the impinger after a 72-hour incubation period.
The number of Bacterial CFUs per location is reported
|
Baseline
|
|
Number of Bacterial Colony Forming Units (CFUs) at Each Location
Time Frame: 1 hour from the start of the treatment
|
At the start of treatment, four agar petri dishes will be placed at standardized distances (2 ft, 3 ft, 4 ft, and 6 ft) from the dental chair headrest in the operating room for one hour.
An impinger will also be positioned 2 ft from the headrest for one hour.
The number of bacterial colony-forming units (CFUs) will be counted for each petri dish and the impinger after a 72-hour incubation period.
The number of Bacterial CFUs per location is reported.
|
1 hour from the start of the treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Claudia Ruiz Brisuela, DDS, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 21, 2021
Primary Completion (Actual)
May 2, 2024
Study Completion (Actual)
May 2, 2024
Study Registration Dates
First Submitted
November 30, 2020
First Submitted That Met QC Criteria
December 8, 2020
First Posted (Actual)
December 9, 2020
Study Record Updates
Last Update Posted (Estimated)
July 8, 2025
Last Update Submitted That Met QC Criteria
June 18, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-DB-20-1017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
-
Erasmus Medical CenterUniversity Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruiting
Clinical Trials on Hydrogen Peroxide
-
Universidad IberoamericanaCompleted
-
Universidade Federal do ParaCompletedColor | Bleaching SensitivityBrazil
-
Ultradent Products, Inc.Indiana University; Universidad IntercontinentalCompletedDental Atraumatic Restorative TreatmentMexico
-
Federal University of UberlandiaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...Completed
-
University of Nove de JulhoUnknown
-
Universidade Federal do ParaCompletedTooth Discoloration | Tooth Sensitivity | Morphologic ChangeBrazil
-
Loma Linda UniversityTerminated
-
University of ChileCompleted
-
Lawson Health Research InstituteRecruitingBasal Cell Carcinoma | Squamous Cell Carcinoma of Skin DifferentiatedCanada
-
University of MiamiCompleted